Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor

Cellular Signalling

Volumn 27, Issue 7, 2015, Pages 1297-1304

  Lecat, Sandra ^a   Belemnaba, Lazare ^b   Galzi, Jean Luc ^a   Bucher, Bernard ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Faculté de Pharmacie   (France)

Author keywords

Extracellular regulated protein kinase; G protein coupled receptor; Human embryonic kidney; IGFR; Neuropeptide Y; arrestin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; BETA ARRESTIN; ENDOTHELIN ETB RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; MARIMASTAT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC M3 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN KINASE D; SOMATOMEDIN RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN; 1,3 BUTADIENE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR; NITRILE; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C RECEPTOR; TYRPHOSTIN;

ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEK293 CELL LINE; INHIBITION KINETICS; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SENSITIVITY ANALYSIS; STABLE EXPRESSION; AGONISTS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

BUTADIENES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEK293 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROPEPTIDE Y; NITRILES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TYRPHOSTINS;

EID: 84926162022     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.03.016     Document Type: Article

References (46)

1. Berglund M.M., Hipskind P.A., Gehlert D.R. Exp. Biol. Med. (Maywood) 2003, 228:217-244.
2. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. Pharmacol. Rev. 1998, 50:143-150.
3. Howell O.W., Doyle K., Goodman J.H., Scharfman H.E., Herzog H., Pringle A., Beck-Sickinger A.G., Gray W.P. J. Neurochem. 2005, 93:560-570.
4. Thiriet N., Agasse F., Nicoleau C., Guegan C., Vallette F., Cadet J.L., Jaber M., Malva J.O., Coronas V. J. Neurochem. 2011, 116:1018-1027.
5. Shimada K., Ohno Y., Okamatsu-Ogura Y., Suzuki M., Kamikawa A., Terao A., Kimura K. Peptides 2012, 34:336-342.
6. Wetzker R., Bohmer F.D. Nat. Rev. Mol. Cell Biol. 2003, 4:651-657.
7. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. Nature 1999, 402:884-888.
8. Pierce K.L., Luttrell L.M., Lefkowitz R.J. Oncogene 2001, 20:1532-1539.
9. Rozengurt E. J. Cell. Physiol. 2007, 213:589-602.
10. Neve K.A. Mol. Pharmacol. 2005, 68:275-278.
11. Shah B.H., Neithardt A., Chu D.B., Shah F.B., Catt K.J. J. Cell. Physiol. 2006, 206:47-57.
12. Defea K. Br. J. Pharmacol. 2008, 153(Suppl. 1):S298-S309.
13. Shenoy S.K., Lefkowitz R.J. Trends Pharmacol. Sci. 2011, 32:521-533.
14. Shenoy S.K., Drake M.T., Nelson C.D., Houtz D.A., Xiao K., Madabushi S., Reiter E., Premont R.T., Lichtarge O., Lefkowitz R.J. J. Biol. Chem. 2006, 281:1261-1273.
15. Gicquiaux H., Lecat S., Gaire M., Dieterlen A., Mely Y., Takeda K., Bucher B., Galzi J.L. J. Biol. Chem. 2002, 277:6645-6655.
16. Ouedraogo M., Lecat S., Rochdi M.D., Hachet-Haas M., Matthes H., Gicquiaux H., Verrier S., Gaire M., Glasser N., Mely Y., Takeda K., Bouvier M., Galzi J.L., Bucher B. Traffic 2008, 9:305-324.
17. Lecat S., Ouedraogo M., Cherrier T., Noulet F., Ronde P., Glasser N., Galzi J.L., Mely Y., Takeda K., Bucher B. Cell. Signal. 2011, 23:228-238.
18. Lehmann D.M., Seneviratne A.M., Smrcka A.V. Mol. Pharmacol. 2008, 73:410-418.
19. Hawes B.E., Luttrell L.M., van Biesen T., Lefkowitz R.J. J. Biol. Chem. 1996, 271:12133-12136.
20. Yart A., Roche S., Wetzker R., Laffargue M., Tonks N., Mayeux P., Chap H., Raynal P. J. Biol. Chem. 2002, 277:21167-21178.
21. Luttrell L.M., Hawes B.E., van Biesen T., Luttrell D.K., Lansing T.J., Lefkowitz R.J. J. Biol. Chem. 1996, 271:19443-19450.
22. Roghani M., Becherer J.D., Moss M.L., Atherton R.E., Erdjument-Bromage H., Arribas J., Blackburn R.K., Weskamp G., Tempst P., Blobel C.P. J. Biol. Chem. 1999, 274:3531-3540.
23. Oligny-Longpre G., Corbani M., Zhou J., Hogue M., Guillon G., Bouvier M. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E1028-E1037.
24. Michel G., Matthes H.W., Hachet-Haas M., El Baghdadi K., de Mey J., Pepperkok R., Simpson J.C., Galzi J.L., Lecat S. J. Cell Sci. 2014, 127:773-787.
25. Charest P.G., Oligny-Longpre G., Bonin H., Azzi M., Bouvier M. Cell. Signal. 2007, 19:32-41.
26. Eisinger D.A., Ammer H. Mol. Pharmacol. 2011, 79:326-335.
27. Luttrell L.M., van Biesen T., Hawes B.E., Koch W.J., Touhara K., Lefkowitz R.J. J. Biol. Chem. 1995, 270:16495-16498.
28. Kurihara S., Hakuno F., Takahashi S. Endocr. J. 2000, 47:739-751.
29. Kuemmerle J.F., Murthy K.S. J. Biol. Chem. 2001, 276:7187-7194.
30. Girnita L., Shenoy S.K., Sehat B., Vasilcanu R., Vasilcanu D., Girnita A., Lefkowitz R.J., Larsson O. J. Biol. Chem. 2007, 282:11329-11338.
31. Delcourt N., Bockaert J., Marin P. Trends Pharmacol. Sci. 2007, 28:602-607.
32. Anastassiadis T., Deacon S.W., Devarajan K., Ma H., Peterson J.R. Nat. Biotechnol. 2011, 29:1039-1045.
33. Christensen G.L., Kelstrup C.D., Lyngso C., Sarwar U., Bogebo R., Sheikh S.P., Gammeltoft S., Olsen J.V., Hansen J.L. Mol. Cell. Proteomics 2010, 9:1540-1553.
34. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., Flavell R.A. Nature 2002, 416:194-199.
35. Lopez-Ilasaca M., Crespo P., Pellici P.G., Gutkind J.S., Wetzker R. Science 1997, 275:394-397.
36. Deane J.A., Fruman D.A. Annu. Rev. Immunol. 2004, 22:563-598.
37. Procko E., McColl S.R. BioEssays 2005, 27:153-163.
38. Del Prete A., Vermi W., Dander E., Otero K., Barberis L., Luini W., Bernasconi S., Sironi M., Santoro A., Garlanda C., Facchetti F., Wymann M.P., Vecchi A., Hirsch E., Mantovani A., Sozzani S. EMBO J. 2004, 23:3505-3515.
39. Delgado-Martin C., Escribano C., Pablos J.L., Riol-Blanco L., Rodriguez-Fernandez J.L. J. Biol. Chem. 2011, 286:37222-37236.
40. Schreiber T.B., Mausbacher N., Keri G., Cox J., Daub H. Mol. Cell. Proteomics 2010, 9:1047-1062.
41. Keffel S., Schmidt M., Bischoff A., Michel M.C. J. Pharmacol. Exp. Ther. 1999, 291:1172-1178.
42. Mullins D.E., Zhang X., Hawes B.E. Regul. Pept. 2002, 105:65-73.
43. Alvaro A.R., Martins J., Araujo I.M., Rosmaninho-Salgado J., Ambrosio A.F., Cavadas C. J. Neurochem. 2008, 105:2501-2510.
44. Cheung A., Newland P.L., Zaben M., Attard G.S., Gray W.P. J. Biol. Chem. 2012, 287:20187-20196.
45. Wang D., Yu X., Cohen R.A., Brecher P. J. Biol. Chem. 2000, 275:12223-12230.
46. Thuringer D., Maulon L., Frelin C. J. Biol. Chem. 2002, 277:2028-2032.